"I wouldn't be here if I had not done the test," he said. Prostate Cancer UK said current NHS guidelines meant it "was each ...

Over the past decade, a growing network of organizations in the world, the nation, the state and the region have transformed the month ...

A new artificial intelligence tool developed by the Hospital Clínic de Barcelona will facilitate the diagnosis of prostate ...

Prostate cancer affects men all over the world and cutting edge research and clinical trials are happening right here in ...

A team led by Dr. Yuri Tolkach at the University of Cologne's Faculty of Medicine and University Hospital Cologne has ...

A groundbreaking approach slows tumor growth while boosting the immune system’s defense against cancer cells. Prostate cancer ranks as the second most common cancer among men globally. Despite recent ...

A leading scientist whose discoveries about prostate cancer led to lifesaving treatments ... transformation in just three months." Currently no drugs exist that target ASCL1.

New research from Cold Spring Harbor Labs shows that a compound related to vitamin K slowed the progression of prostate cancer in lab mice, offering a path for further study into one of the most ...

and has disclosed no relevant affiliations beyond their academic appointment. Prostate cancer is Australia’s most commonly diagnosed cancer. One in six men will be diagnosed by the time they ...

In 2001, the National Cancer Institute's SELECT trial sought to determine if an antioxidant vitamin E supplement could successfully treat or prevent prostate cancer. The trial involving 35,000 men ...

Currently, there is no standard test to screen for prostate cancer. If symptoms are reported, a physician may draw blood for a prostate-specific antigen test (PSA), which screens for hormone ...

Prostate cancer - abnormal and uncontrolled cell growth - often develops slowly. There may be no signs or symptoms for years and some people never develop any problems from it. But in others ...